Stoke Therapeutics STOK
NASDAQ STOK
$25.62 -0.39 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Cash & Current Investments (2018 - 2026)

Updated

Stoke Therapeutics' Cash & Current Investments was $292.82 million in Q2 2026, up 18.2% from $247.71 million a year earlier but down 14.8% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Stoke Therapeutics came in at $284.67 million, up 31.2% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $216.9 million in FY2024 (+7.7%), $201.39 million in FY2023 (-12.3%), $229.6 million in FY2022 (+4.5%) and $219.81 million in FY2021 (-23.5%).
  • Quarterly Cash & Current Investments has moved between $178.58 million (Q1 2024) and $357.32 million (Q1 2025) over five years.
  • Compared with a year earlier, Cash & Current Investments was higher in six of the last eight quarters, with growth averaging 19.6%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2025 (growth of 100.1%); the worst was Q1 2024 (a decline of 29.6%).
  • Per Business Quant data, STOK's Cash & Current Investments in the three quarters before Q2 2026 was $343.55 million (Q1 2026), $284.67 million (Q4 2025) and $248.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Stoke Therapeutics 1.60 Bn 429.41 Mn - 292.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 292.82 Mn
Mar 31, 2026 343.55 Mn
Dec 31, 2025 284.67 Mn
Sep 30, 2025 248.31 Mn
Jun 30, 2025 247.71 Mn
Mar 31, 2025 357.32 Mn
Dec 31, 2024 216.90 Mn
Sep 30, 2024 239.20 Mn
Jun 30, 2024 281.98 Mn
Mar 31, 2024 178.58 Mn
Dec 31, 2023 201.39 Mn
Sep 30, 2023 214.72 Mn
Jun 30, 2023 231.45 Mn
Mar 31, 2023 253.67 Mn
Dec 31, 2022 229.60 Mn
Sep 30, 2022 251.66 Mn
Jun 30, 2022 275.63 Mn
Mar 31, 2022 293.22 Mn
Dec 31, 2021 219.81 Mn
Sep 30, 2021 236.16 Mn
API Access

Stoke Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=STOK&period=max&api_key=YOUR_API_KEY